Hyperfine’s AI-Powered Portable MRI Achieves 100% Sensitivity in ARIA-E Detection at 2025 Alzheimer’s Conference

Hyperfine’s AI-Powered Portable MRI Achieves 100% Sensitivity in ARIA-E Detection at 2025 Alzheimer’s Conference

The groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—announced promising early results from the CARE PMR (Capturing ARIA Risk Equitably with Portable MR) study presented at the…

Read MoreHyperfine’s AI-Powered Portable MRI Achieves 100% Sensitivity in ARIA-E Detection at 2025 Alzheimer’s Conference
Prilenia and Ferrer Share European Regulatory Update on Pridopidine for Huntington’s Disease

Prilenia and Ferrer Share European Regulatory Update on Pridopidine for Huntington’s Disease

Prilenia Therapeutics B.V. and Ferrer today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the refusal of the marketing authorization for pridopidine’s marketing authorization application for Huntington’s disease (HD). We are disappointed, but undeterred…

Read MorePrilenia and Ferrer Share European Regulatory Update on Pridopidine for Huntington’s Disease
Leveragen and Propeller Bio Partner to Advance Antibody and Protein Therapies

Leveragen and Propeller Bio Partner to Advance Antibody and Protein Therapies

A Boston-based biotechnology company pioneering next-generation in vivo antibody discovery platforms, announced today a strategic collaboration with Propeller Bio, a newly launched biotechnology company focused on antibody and protein-based therapeutics. As part of the partnership, Propeller Bio will support the…

Read MoreLeveragen and Propeller Bio Partner to Advance Antibody and Protein Therapies

Vektor Medical’s vMap Tops 2,000 Procedures, Setting a New Benchmark in Arrhythmia Care

Vektor Medical today announced its vMap® system has been used in more than 2,000 procedures in the U.S., a milestone that underscores its rapid adoption by electrophysiologists (EPs) and hospitals seeking to improve procedural efficiency, reduce repeat interventions, and deliver better patient…

Read MoreVektor Medical’s vMap Tops 2,000 Procedures, Setting a New Benchmark in Arrhythmia Care
Sunflower Therapeutics Signs Exclusive Distribution Deal with Alflow Scandinavia AS

Sunflower Therapeutics Signs Exclusive Distribution Deal with Alflow Scandinavia A/S

A public benefit corporation transforming global access to protein manufacturing capacity for diverse applications, announced today that it has engaged Alflow Scandinavia A/S as its exclusive distributor for the Daisy Petal™ Perfusion Bioreactor System in Denmark, Norway, Sweden, and Iceland. This marks…

Read MoreSunflower Therapeutics Signs Exclusive Distribution Deal with Alflow Scandinavia A/S
Komodo Health and Anervea.ai Partner to Advance Next-Gen Healthcare AI and Transform Clinical Development

Komodo Health and Anervea.ai Team Up to Transform Clinical Development with Next-Gen AI

Komodo Health, the Evidentiary Standard for real-world patient-journey insights and healthcare analytics, today announced a strategic partnership with Anervea.ai, an AI-native Life Sciences technology company, to accelerate innovation across Clinical Development. Among the top biopharma companies, the average investment required…

Read MoreKomodo Health and Anervea.ai Team Up to Transform Clinical Development with Next-Gen AI
Flatiron Health Expands Global Oncology Research Network Threefold to Advance Multinational Evidence Generation

Flatiron Health Triples Global Oncology Network to Boost Multinational Evidence Generation

Flatiron Health, a leading healthtech company dedicated to improving cancer care and advancing research using real-world data (RWD), today announced that its international oncology research network has tripled in size across the UK, Germany, and Japan over the past year—a…

Read MoreFlatiron Health Triples Global Oncology Network to Boost Multinational Evidence Generation
Sutter Health Hospitals Deploy Wearable Ultrasound Tech to Personalize Fluid Management for Sepsis

Sutter Health Uses Wearable Ultrasound to Personalize Sepsis Fluid Management

Sutter Health, an integrated not-for-profit healthcare system based in Northern California, and Flosonics Medical today announced an expansion of the deployment of FloPatch, the first wireless wearable Doppler ultrasound device, across multiple hospital sites to support more precise and timely…

Read MoreSutter Health Uses Wearable Ultrasound to Personalize Sepsis Fluid Management